2021
NAFLD-related HCC
Banini BA, Sanyal AJ. NAFLD-related HCC. Advances In Cancer Research 2021, 149: 143-169. PMID: 33579423, DOI: 10.1016/bs.acr.2020.11.001.ChaptersConceptsNonalcoholic fatty liver diseaseHepatocellular carcinomaType 2 diabetes mellitusFatty liver diseaseNumber of patientsDiabetes mellitusMetabolic syndromeLiver diseaseCurrent evidenceMain molecular mechanismsMetabolic perturbationsTwo- toUnites StatesMolecular mechanismsMellitusObesityPatientsCarcinomaGlobal increaseSyndromeDiseaseIncidenceHepatocarcinogenesis
2016
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options
Banini BA, Sanyal AJ. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. Clinical Medicine Insights Therapeutics 2016, 8: cmt.s18885. PMID: 28670148, PMCID: PMC5491796, DOI: 10.4137/cmt.s18885.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNonalcoholic fatty liver diseaseLiver diseaseManagement of NAFLDPathogenesis of NAFLDAdvanced phase clinical trialsLiver-related outcomesCornerstone of treatmentFirst-line therapyHigh-risk patientsChronic liver diseaseFatty liver diseaseCurrent treatment optionsHepatic manifestationNAFLD patientsMetabolic syndromeMajor etiologyInsulin resistancePharmacologic interventionsTreatment optionsClinical evaluationClinical trialsHigh riskVitamin ENatural historyPatients